scholarly journals International benchmarking for health policy evaluation: the French National Health Strategy

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
L Luciano ◽  
E Low ◽  
S Rey ◽  
M Gaini

Abstract Background International benchmarking is a valued source of inspiration and learning for policy-makers to develop successful public health policies. Through comparison, the external coherence of one policy can be measured and its objectives redesigned. The French national health strategy (SNS) 2018-2022 comprises the French health policy framework focusing on four priority areas. The aim of this study was to conduct international benchmarking of current national health strategies to explore the external coherence of the SNS and evaluation methods. Methods A scoping review was conducted through available governmental and public health agencies' websites to survey national/federal health strategies in select high-income countries. Strategical approaches, governance and policy duration were compared with four health priorities of the French SNS: prevention, social/territorial inequalities, quality of care, innovation. A descriptive analysis of these strategies' evaluation methods, including relevant indicators, was executed. Results Out of 18 countries selected, 11 have a current strategy akin to the four priorities of the French SNS, with a timeline stipulated to implement the policy. The strategies of Australia and Switzerland, out of nine countries with strategies covering these areas, bear the closest resemblance to the French SNS. Evaluation methods varied largely across countries. Conclusions The majority of countries contain a health strategy with a longer duration compared to the French SNS, irrespective of governance. Similar priorities were found for countries with a national health strategy, with other countries developing at least prevention plans. Most countries provided only partial evaluation methods or overall health target indicators, to be taken into account for the development of the French SNS evaluation plan Key messages International benchmarking is essential to identify best practices in health policy design. As a result, future French health strategies may benefit from a longer duration of implementation. If great efforts were put in place in France to build a strategy evaluation plan, other countries focused mostly on implementation reports or monitoring national health targets through indicators.

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
P Arwidson

Abstract In 2009, the hospitals, health and territories act has entrusted the responsibility for care and public health to the regional health agencies. This decentralisation aims to adapt strategies to local situations. These regional agencies have a very strong autonomy. In 2013, it was stated in the national health strategy that it was necessary to develop a scientifically based prevention. Two tracks are to be followed: either by importing and adapting validated or promising programs by identifying effective programs in the international literature; or from existing French initiatives (tobacco, alcohol, psychoactive substances, physical activity). The high prevalence of smoking motivated the establishment of a National tobacco reduction program in 2014, which was then relayed by a national tobacco control program. In 2016, the Health System Improvement Act created a major national public health agency combining surveillance, prevention, health promotion and emergency response. The motivation was to achieve greater synergy and collaboration between the different functions in public health. A report from the Inspectorate General of Social Affairs has recommended that this agency should establish a national portal with evidence-based prevention and health promotion programmes. Established in 2018, the Priority Prevention Plan is a major interdepartmental project to improve the health of the population, and is part of the National Health Strategy. This interdepartmental approach reflects the Government’s desire that all ministries should be able to contribute to prevention and health promotion. The increased investment in prevention and health promotion is starting to bear fruit with 1.6 million fewer smokers between 2016 and 2018. Immunisation coverage has also been improved. NutriScore, a nutritional information on the front of food containers, very easy to understand, has been put in place with partnership with 100 companies.


2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
N Lindqvist

Abstract Public health issues and their equality aspects have been on the political agenda in Sweden since the early 1980s. Already in the 1990s, the Government presented the first public health policy bill. This highlighted the conditions for a sustainable development from a public health perspective. Increased equality was set to be the overriding objective in prioritizing public health work and that priority should be given to efforts that would improve the situation of the most disadvantaged. The foundation of today’s public health policy was laid in 2003 when the parliament decided on a new bill in which an overall goal for national public health policy was established: ‘Creating social conditions for good health on equal terms for the entire population’. The bill also established a cross-sectoral target structure for the overall public health work with eleven target areas. It also pointed out that public health policy is cross-sectoral and must be a part in all policy areas. In June 2008, the parliament adopted the bill A Renewed Public Health Policy. Changes made were (among other things) a rewording of the target areas, but many of the starting points were kept. The Swedish Commission for Equity in Health was set up in 2015 and given two main tasks, to produce a proposal that can help to reduce the health inequalities in society and to work for raised awareness of health inequalities in society and among stakeholders. The work of the commission was finished in 2017 and presents an analysis of how the public health policy works in practice, with regard to the intentions of policy framework. A number of problems or areas of development appear which the Commission considers need to be addressed. The presentation will first give a short overview of the Swedish public health policy from 2008 and will then present the commission’s conclusions and proposals for development areas.


2016 ◽  
Vol 6 (1) ◽  
pp. 525-27 ◽  
Author(s):  
Om Kurmi ◽  
Pramod R Regmi ◽  
Puspa Raj Pant

Correction 7th May 2016: p.256 Column 2, paragraph 3, line 7 - 'National Health Policy of Nepal (2015/16)' changed TO 'National Health Policy of Nepal (2014)'.The Nepal Health Research Council and recent National Health Policy of Nepal (2015/16) have included ‘air pollution’ as a priority research/public health agenda that is guaranteed by the Constitution. There is an urgent need to organise the future policies and actions to ensure the commitments to reduce air pollution.


2010 ◽  
Vol 24 (4) ◽  
pp. 395-414 ◽  
Author(s):  
Meri Koivusalo

In order to achieve more ethical global health outcomes, health policies must be driven by health priorities and should take into account broader health policy requirements, including the needs of specific national health systems. It is thus important to recognize that the division of interests in key policy areas are not necessarily between the priorities of rich and poor countries, but between (1) pharmaceutical industry interests and health policy interests, and (2) national industrial and trade policy interests and public health policies. In this article I will focus on two broad common interests for health policy officials. Both have become important in the context of current global negotiations relating to access to medicines; pandemic influenza; and public health, innovation, and intellectual property rights. These are (1) ensuring access, availability, and the safety of pharmaceuticals, and (2) ensuring that research-and-development efforts respond to public health needs. I argue that these issues are not solely the concern of developing countries because the diminishing national policy space for health in pharmaceutical policies presents a challenge to all governments, including rich ones.


2020 ◽  
Author(s):  
Antoine Rachas ◽  
Christelle Gastaldi-Menager ◽  
Pierre Denis ◽  
Thomas Lesuffleur ◽  
Muriel Nicolas ◽  
...  

Background Description of the prevalence of diseases and resources mobilized for the management of each disease is essential to identify public health priorities. We described the prevalences of 58 health conditions and all reimbursed healthcare expenditure by health condition in France between 2012 and 2017. Methods and Findings All national health insurance general scheme beneficiaries (87% of the French population) with at least one reimbursed healthcare expenditure were included from the French national health database. We identified health conditions (diseases, episodes of care, chronic treatments) by algorithms using ICD-10 codes for long-term diseases or hospitalisations, medications or medical procedures. We reported crude and age and sex-standardized annual prevalences between 2012 and 2017, and total and mean (per patient) reimbursed expenditure attributed to each condition without double counting, and according to the type of expenditure. In 2017, in a population of 57.6 million people (54% of women, median age: 40 years), the most prevalent diseases were diabetes (standardized prevalence: 5.8%), chronic respiratory diseases (5.5%) and chronic coronary heart disease (2.9%). Diseases concentrating the highest expenditures were active cancers (10% of total expenditure of 140.1 billion euros), mental illness (10%; neurotic and mood disorders: 4%; psychotic disorders: 3%), and chronic cardiovascular diseases (8%). Between 2012 and 2017, the most marked increase in total expenditure concerned liver and pancreatic diseases (+9.3%), related to the increased drug expenditure in 2014. Conversely, the increase in the number of patients (and the prevalence) explained the majority of the increase of total expenditures for cardiovascular disease, diabetes and mental illness. Conclusions These results showed a regular increase of the prevalence and expenditure of certain chronic diseases, probably related to ageing of the population, and increased expenditures related to major therapeutic innovations. The Diseases and Healthcare Expenditure Mapping therefore enlightens decision-makers in charge of public health and health accounts.


2021 ◽  
Vol 9 (02) ◽  
pp. 373-402
Author(s):  
Bernard Nkala ◽  
◽  
Gordon Liu ◽  

The study investigated the determinants of access and utilization of specialty healthcare services in the case of public referral hospitals in Zimbabwe using the period post-independence in 1980s to 2018. This becomes an exciting period for the study as it presents the rise and fall of Zimbabwe’s healthcare system. Although there are many specialists offering specialty healthcare, the study limited its focus on specialty care physicians operating at public health facilities. The study objectives were to identify the socio-economic and health behavioural determinants that could influence access to and utilization of specialty healthcare amongst different groupings in Zimbabwe. The study specifically examined the influence of household income, insurance, health information/ education, distance to the nearest health centre, waiting time and dual practice as a variable of interest on access to specialty care. The study utilized cross-sectional household data collected through a survey from April to October 2019. Out of the 40 selected districts from a cluster of 63 existing administrative health districts, 1000 households were randomly selected using one stage cluster sampling (probability sampling design). The study used the Logistic regression model to identify the determinants of access to and utilisation of specialty healthcare based on 653 households that had reported sickness of a member within the last twelve months before the survey. The study tested the hypotheses that dual practice does not affect the supply capacity at public hospitals hence does not reduce access and utilisation of specialty healthcare household income does not increase the demand for specialized healthcare services and that the distance to the nearest health facility does not reduce the probability of seeking of specialty healthcare services. The Logistic regression results revealed that distance to the nearest health care facility, household income, health insurance coverage, presence of dual practice and waiting time all had a significant statistical relationship with access and utilization (demand) for specialty healthcare at public health institutions. However, the study found out that health information had negative effect though an insignificant variable. Distance to the nearest health facility and waiting time was found to negatively affect access (demand) to specialty healthcare whereas household income, dual practice and insurance coverage were found to positively influence access and utilization of specialty healthcare at public health institutions. The study established that, as there is an increase in income and insurance coverage, access and utilization of specialty care also increased. More households in Zimbabwe (71%) are not medically insured. The study found that the provision of specialty healthcare services is too centralized thereby patients are compelled to travel long distancesto metropolitan facilities where specialty health services are more concentrated. The study further established that dual practice affects the supply capacity in public hospitals. The constraining arrangement of management and teaching services at main teaching hospitals affects the supply of specialty services. Households tend to wait longer to consult specialists at public hospitals due to poorly regulated dual practice that induces long waiting times. Given the study findings, the study recommends health policy planners to adopt a balanced centralized and decentralized modelon access to specialty care, differentiating higher and lower tier specialty care facilities to address the geographic accessibility and availability dimensions and revisiting management of training and structuring of specialty teaching services. Other major recommendations of the study include the review of supply-side policies used to enhance access to specialty healthcare services. The policies may target at implementing a public sector ‘National Health Insurance Fund’, driven by the government of Zimbabwe offering realistic, acceptable and affordable premiums for vulnerable groups and expanding the scope of participation in developing the policy regulating dual practice. The study also recommends the creation of Special Economic Zones (SEZ) for Specialty health riding on the existing Government framework on SEZs. The adoption of Strategic Specialty care Partnerships (SSCPs) can enhance access and institutional capacities in dealing with the expensive response to Non Communicable Diseases, which are the main drivers for households to seek specialty care. Zimbabwe through its national health authority needs to ‘Reframe the Health Agenda’ on specialty care thus initiate a national health action plan that will continue to drive to evidence-based health policy and practice.


2018 ◽  
Vol 13 (3) ◽  
pp. ii
Author(s):  
David Briggs

Recently I was talking to a colleague of mine from Hong Kong and he reminded me that Hong Kong had had 28 years of health reform. A period just slightly longer than we had known each other. We are deeply imbued in the management and organisation of health services and health systems and, therefore public health policy. He suggested that there should be a lot of learning for us all from that period and, he was exploring how that might happen. I agreed with the idea and the need to think it through. I also recognised potential for the Journal to play some role in that suggestion. Most national health systems have undergone extensive reform so there should be a lot of learning for all of us from that reform.....


2018 ◽  
Vol 12 (3) ◽  
pp. 462-466
Author(s):  
Barna Ganguli ◽  
Bakshi Amit Kumar Sinha

This commentary seeks to critically evaluate the new National Health Policy, which emerged as a comprehensive document for Universal Health Coverage in India. Whether the new initiative, with its emphasis on the alignment of private healthcare sector with public health, is merely a window dressing of the old health policies or does it offer something substantive and new?


Sign in / Sign up

Export Citation Format

Share Document